The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Bruns Ingmar since 2025.
This trader's CIK number is 1838041.
At the time of last reporting, Bruns Ingmar was the Chief Medical Officer of Zentalis Pharmaceuticals, Inc.. (stock ticker symbol ZNTL).
Also see all insider trading activities at Zentalis Pharmaceuticals, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | ZNTL | 20,000 | $45,660 | 0 | $0 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-02-06 | ZNTL | Buy | 20,000 | 2.28 | 45,660 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Bruns Ingmar (Chief Medical Officer of Zentalis Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.